These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

768 related items for PubMed ID: 24881491

  • 1. Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
    Coffin CS, Mulrooney-Cousins PM, Osiowy C, van der Meer F, Nishikawa S, Michalak TI, van Marle G, Gill MJ.
    J Clin Virol; 2014 Aug; 60(4):347-53. PubMed ID: 24881491
    [Abstract] [Full Text] [Related]

  • 2. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM.
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [Abstract] [Full Text] [Related]

  • 3. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
    Gachara G, Magoro T, Mavhandu L, Lum E, Kimbi HK, Ndip RN, Bessong PO.
    AIDS Res Ther; 2017 Mar 08; 14(1):11. PubMed ID: 28270215
    [Abstract] [Full Text] [Related]

  • 4. A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection.
    Cassini R, De Mitri MS, Gibellini D, Urbinati L, Bagaglio S, Morsica G, Domenicali M, Verucchi G, Bernardi M.
    J Viral Hepat; 2013 Jan 08; 20(1):42-9. PubMed ID: 23231083
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group.
    Transfusion; 2014 Aug 08; 54(8):2084-91. PubMed ID: 24650170
    [Abstract] [Full Text] [Related]

  • 6. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.
    J Med Virol; 2009 Mar 08; 81(3):441-5. PubMed ID: 19152397
    [Abstract] [Full Text] [Related]

  • 7. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
    Motta JS, Mello FC, Lago BV, Perez RM, Gomes SA, Figueiredo FF.
    J Gastroenterol Hepatol; 2010 Jan 08; 25(1):101-6. PubMed ID: 19817965
    [Abstract] [Full Text] [Related]

  • 8. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar 08; 21(3):189-91. PubMed ID: 23967739
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.
    Biol Blood Marrow Transplant; 2010 Jun 08; 16(6):809-17. PubMed ID: 20060484
    [Abstract] [Full Text] [Related]

  • 10. Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients.
    Pogány K, Zaaijer HL, Prins JM, Wit FW, Lange JM, Beld MG.
    AIDS Res Hum Retroviruses; 2005 Nov 08; 21(11):922-6. PubMed ID: 16386107
    [Abstract] [Full Text] [Related]

  • 11. Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon.
    Kouanfack C, Aghokeng AF, Mondain AM, Bourgeois A, Kenfack A, Mpoudi-Ngolé E, Ducos J, Delaporte E, Laurent C.
    Antivir Ther; 2012 Nov 08; 17(2):321-6. PubMed ID: 22290198
    [Abstract] [Full Text] [Related]

  • 12. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations.
    Sucupira MV, Mello FC, Santos EA, Niel C, Rolla VC, Arabe J, Gomes SA.
    Mem Inst Oswaldo Cruz; 2006 Sep 08; 101(6):655-60. PubMed ID: 17072479
    [Abstract] [Full Text] [Related]

  • 13. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S, Singh S.
    BMC Infect Dis; 2010 Mar 07; 10():53. PubMed ID: 20205948
    [Abstract] [Full Text] [Related]

  • 14. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
    Oliveira MP, Lemes PS, Matos MA, Del-Rios NH, Carneiro MA, Silva ÁM, Lopes CL, Teles SA, Aires RS, Lago BV, Araujo NM, Martins RM.
    J Med Virol; 2016 Jul 07; 88(7):1222-9. PubMed ID: 27061406
    [Abstract] [Full Text] [Related]

  • 15. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan 07; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 16. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
    Azadmanesh K, Mohraz M, Aghakhani A, Edalat R, Jam S, Eslamifar A, Banifazl M, Moradmand-Badie B, Ramezani A.
    Intervirology; 2008 Jan 07; 51(4):270-4. PubMed ID: 18841029
    [Abstract] [Full Text] [Related]

  • 17. High incidence of lamivudine-resistance-associated vaccine-escape HBV mutants among HIV-coinfected patients on prolonged antiretroviral therapy.
    Pal A, Sarkar N, Saha D, Guha SK, Saha B, Chakrabarti S, Chakravarty R.
    Antivir Ther; 2015 Jan 07; 20(5):545-54. PubMed ID: 25654813
    [Abstract] [Full Text] [Related]

  • 18. Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection.
    Tajik Z, Bokharaei-Salim F, Ghorbani S, Keyvani H, Esghaei M, Monavari SH, Ataei-Pirkooh A, Garshasbi S, Donyavi T, Fakhim A.
    Arch Virol; 2018 Jun 07; 163(6):1559-1566. PubMed ID: 29476259
    [Abstract] [Full Text] [Related]

  • 19. Occult hepatitis B virus infection with positive hepatitis B e antigen.
    Han Z, Liu Y, Pan J, Bi Y, Liu J, Zhou YH.
    Clin Chim Acta; 2015 Jan 01; 438():266-8. PubMed ID: 25218700
    [Abstract] [Full Text] [Related]

  • 20. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
    Datta S, Banerjee A, Chandra PK, Chowdhury A, Chakravarty R.
    J Med Virol; 2006 Jan 01; 78(1):53-9. PubMed ID: 16299727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.